Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

S1P1 Receptor Modulation with Cyclical Recovery from Lymphopenia Ameliorates Mouse Model of Multiple Sclerosis

Pedro J. Gonzalez-Cabrera, Stuart M. Cahalan, Nhan Nguyen, Gor Sarkisyan, Nora B. Leaf, Michael D. Cameron, Tomoyuki Kago and Hugh Rosen
Molecular Pharmacology February 2012, 81 (2) 166-174; DOI: https://doi.org/10.1124/mol.111.076109
Pedro J. Gonzalez-Cabrera
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stuart M. Cahalan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nhan Nguyen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gor Sarkisyan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nora B. Leaf
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael D. Cameron
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomoyuki Kago
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hugh Rosen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 81 no. 2 166-174
DOI 
https://doi.org/10.1124/mol.111.076109
PubMed 
22031473

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received September 27, 2011
  • Accepted October 26, 2011
  • Published online January 17, 2012.

Article Versions

  • Earlier version (October 26, 2011 - 08:58).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2012 The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Pedro J. Gonzalez-Cabrera,
  2. Stuart M. Cahalan,
  3. Nhan Nguyen,
  4. Gor Sarkisyan,
  5. Nora B. Leaf,
  6. Michael D. Cameron,
  7. Tomoyuki Kago1 and
  8. Hugh Rosen
  1. Departments of Chemical Physiology (P.J.G.C., S.M.C., N.N., G.S., N.B.L., T.K., H.R.) and Immunology (S.M.C.), The Scripps Research Institute, La Jolla, California; and Department of Molecular Therapeutics, The Scripps Research Institute, Jupiter, Florida (M.D.C.)
  1. Address correspondence to:
    Dr Hugh Rosen, Department of Chemical Physiology, Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA 92037. E-mail: hrosen{at}scripps.edu
  1. P.J.G.C. and S.M.C. contributed equally to this work.

  • ↵1 Current affiliation: Kyorin Pharmaceutical Co., Pharmacology Division, Tochigi, Japan.

View Full Text

Statistics from Altmetric.com

Article usage

Article usage: October 2011 to March 2023

AbstractFullPdf
Oct 2011105083
Nov 20111310277
Dec 2011540106
Jan 201231929122
Feb 20122875275
Mar 20121493561
Apr 2012802238
May 2012674144
Jun 2012191118
Jul 2012341716
Aug 2012401222
Sep 2012591836
Oct 2012381816
Nov 2012311921
Dec 20123768
Jan 2013561620
Feb 2013512634
Mar 2013511417
Apr 2013483035
May 2013531922
Jun 2013222020
Jul 2013301511
Aug 2013242211
Sep 2013331621
Oct 201333187
Nov 2013242518
Dec 2013191518
Jan 2014162418
Feb 2014121216
Mar 2014152011
Apr 2014251227
May 2014211529
Jun 2014261826
Jul 2014351618
Aug 20149186
Sep 2014192417
Oct 2014172413
Nov 201422120
Dec 2014132115
Jan 2015303513
Feb 2015131713
Mar 201518239
Apr 2015121610
May 2015232418
Jun 201512157
Jul 2015191813
Aug 20152256
Sep 2015161210
Oct 201510138
Nov 201519711
Dec 20151388
Jan 2016201619
Feb 2016311722
Mar 201615719
Apr 2016212120
May 2016312020
Jun 201613721
Jul 2016121020
Aug 2016331115
Sep 2016111016
Oct 20165175
Nov 201681615
Dec 20162131
Jan 20170218
Feb 20170144
Mar 20175198
Apr 20173192
May 20177193
Jun 20173102
Jul 20171196
Aug 20174205
Sep 20170145
Oct 20174268
Nov 20172269
Dec 20176247
Jan 20184115
Feb 201831411
Mar 20186205
Apr 201862310
May 201831818
Jun 20182289
Jul 201842010
Aug 201808810
Sep 20180356
Oct 201815514
Nov 20180635
Dec 20183997
Jan 20195602
Feb 20193615
Mar 20191701
Apr 20191602
May 20191100
Jun 20191538
Jul 20191414
Aug 20191931
Sep 20191410
Oct 20191934
Nov 20191602
Dec 20191582
Jan 2020822
Feb 20201041
Mar 2020510
Apr 2020611
May 2020610
Jun 2020500
Jul 20201431
Aug 2020102
Sep 20201913
Oct 2020854
Nov 2020901
Dec 20201750
Jan 20211425
Feb 20211978
Mar 20211911
Apr 20211920
May 20213884
Jun 20211422
Jul 20211524
Aug 20211323
Sep 20212531
Oct 20212345
Nov 2021832
Dec 20211921
Jan 20221411
Feb 20221023
Mar 20225134
Apr 20226211
May 20222231
Jun 20221710
Jul 20222264
Aug 20223121
Sep 2022522
Oct 20221524
Nov 20221123
Dec 20221031
Jan 20232640
Feb 20231454
Mar 20232021

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 81 (2)
Molecular Pharmacology
Vol. 81, Issue 2
1 Feb 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
S1P1 Receptor Modulation with Cyclical Recovery from Lymphopenia Ameliorates Mouse Model of Multiple Sclerosis
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

EAE Efficacy of S1P1 Agonism without Sustained Lymphopenia

Pedro J. Gonzalez-Cabrera, Stuart M. Cahalan, Nhan Nguyen, Gor Sarkisyan, Nora B. Leaf, Michael D. Cameron, Tomoyuki Kago and Hugh Rosen
Molecular Pharmacology February 1, 2012, 81 (2) 166-174; DOI: https://doi.org/10.1124/mol.111.076109

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

EAE Efficacy of S1P1 Agonism without Sustained Lymphopenia

Pedro J. Gonzalez-Cabrera, Stuart M. Cahalan, Nhan Nguyen, Gor Sarkisyan, Nora B. Leaf, Michael D. Cameron, Tomoyuki Kago and Hugh Rosen
Molecular Pharmacology February 1, 2012, 81 (2) 166-174; DOI: https://doi.org/10.1124/mol.111.076109
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Mechanism of the selective action of paraherquamide A
  • Use-Dependent Relief of A-887826 Inhibition
  • Benzbromarone Relaxes Airway Smooth Muscle via BK Activation
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics